Immunomedics, Inc.
Edit Page
Report
Scan day: 17 February 2014 UTC
12
Virus safety - good
Description: Researches, develops, manufactures and sells monoclonals and ELISA kits, for use in cancer diagnosis, detection and therapy. Includes clinical overview, investor details and distributor network based in Morris Plains, New Jersey. (Nasdaq: IMMU)
Immunomedics - MONOCLONAL ANTIBODY, CANCER, AUTOIMMUNE DISEASE, BIOTECH, PERSONALIZED MEDICINE, ANTIBODY-DRUG CONJUGATES Second Quarter and Fiscal Year 2014 Results Immunomedics is committed to be a leading, innovative biopharmaceutical company, dedicated to improving patient's health and quality of life with novel antibody–based therapeutics for the treatment of cancer, autoimmune and other serious diseases. Our work is driven by scientific excellence and the highest standards, in a culture of integrity, pride and dedication. In doing so, we create value for our shareholders and a rewarding environment for our employees.
Size: 644 chars
Contact Information
Email:Send Message
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Immunomedics - MONOCLONAL ANTIBODY, CANCER, AUTOIMMUNE DISEASE, BIOTECH, PERSONALIZED MEDICINE, ANTIBODY-DRUG CONJUGATES |
| Keywords: | |
| Description: | |
| IP-address: | 207.111.78.45 |
WHOIS Info
| NS | Name Server: DNS1.CV.NET Name Server: DNS1.CVNET.COM |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 01-aug-1996 Expiration Date: 31-jul-2016 |